Copper storage disease in dogs: liver damage and treatment

Overview

Copper is an essential trace element needed by several enzymes. The liver processes absorbed dietary copper and removes excess in bile. In copper toxicosis, this balance is disrupted and liver cell storage capacity may be exceeded.

About 1/3 of dogs with chronic hepatitis are estimated to have copper-associated hepatitis. This concerns dogs with liver disease, rather than the risk for all dogs. Accumulation can lead to inflammation, fibrosis and eventually cirrhosis.

Copper may accumulate before blood liver enzymes rise or symptoms begin. Demonstrating accumulation and assessing its tissue damage are separate parts of the same diagnosis.

Causes

Genetics and dietary copper act together

Liver copper may increase through excessive intake, impaired bile secretion or other liver disease. Not every high concentration therefore represents the same inherited disorder. A recessively inherited COMMD1 variant is recognised in Bedlington Terriers. In Labrador Retrievers, variants including those in ATP7B are associated with accumulation.

Copper's chemical form influences dietary absorption. Genetics also affects transport and removal from the body. Acute excessive intake of a soluble copper product differs from gradual liver accumulation.

Cell damage sustains inflammation

Free copper increases oxidative stress and damages liver cell energy production. Cell damage triggers an inflammatory response that can become chronic. Inflammation activates fibrosis and gradually alters normal liver structure.

Risk factors

Predisposed breeds include Bedlington Terriers, Labrador Retrievers, Dobermanns, Dalmatians and West Highland White Terriers. However, other breeds and crossbreeds also develop the disease. Females are affected more often than males in Labradors and Dobermanns.

Diagnosis usually occurs in middle-aged or older dogs, although accumulation may begin earlier. Bedlington Terrier symptoms most commonly begin at around 4–6 years. High intake of absorbable copper can increase the burden even without known breed predisposition.

In Dobermanns, accumulation may accompany immune-mediated inflammation, making disease more severe than in other breeds. Family history complements genetic results when assessing individual risk.

Typical symptoms

About 1/4 of copper-associated hepatitis patients initially have no visible symptoms. Raised liver enzymes on routine blood testing may be the first finding. Early symptoms are often vague and resemble other internal organ diseases.

• Appetite decreases and food is left uneaten more often.
• Your dog becomes tired and more subdued.
• Weight falls and your dog may gradually waste away.
• Vomiting or recurrent diarrhoea occurs.
• Increased thirst accompanies greater urination.
• Mucous membranes or the whites of the eyes become yellow.
• The abdomen enlarges with fluid.

Advanced liver failure can cause behavioural changes and neurological signs. In dogs, these relate to liver dysfunction rather than demonstrated brain copper accumulation like that in human Wilson disease.

Muscle mass may also decrease as disease progresses, alongside weight loss.

Complications and consequences

Cirrhosis disrupts circulation and metabolism

In cirrhosis, fibrous tissue replaces functioning liver tissue and permanently alters structure. Portal venous pressure through the liver may rise, causing abdominal fluid accumulation. Severe disease may lower blood albumin and increase bilirubin. Blood glucose may fall excessively in end-stage disease.

Some dogs develop renal tubular dysfunction called Fanconi syndrome. Glucose or protein may then be lost in urine. This generally resolves with treatment of copper-associated hepatitis. Anaemia from red blood cell destruction is possible but uncommon in dogs.

Advanced liver disease can cause either excessive or impaired clotting.

Early treatment improves the outlook

With prompt treatment, the outlook is generally good to very good. Acute liver failure and cirrhosis worsen it. A high liver enzyme result does not directly indicate remaining lifespan.

Diagnosis at the vet

Blood tests and ultrasound assess the situation

Your vet reviews symptoms and performs a general examination before targeted liver tests. Basic tests include a blood count, biochemistry and urine analysis. Raised ALT indicates liver cell damage but not its cause. Bile acids, bilirubin and albumin help assess liver function.

Ultrasound looks for structural changes and consequences such as abdominal fluid. A normal scan does not exclude chronic hepatitis. Blood copper does not reliably reflect liver copper quantity.

Biopsy and copper measurement confirm diagnosis

Diagnosis requires liver tissue examination and copper measurement in a tissue sample. Special staining establishes where copper lies within liver cells. Biopsy also assesses inflammatory activity and fibrosis.

Affected liver copper often exceeds 1,000 micrograms per gram of dry tissue. A concentration of 600–1,000 micrograms per gram is a grey area in which copper-associated hepatitis may nevertheless be present. Copper quantity can vary between lobes. Extensive fibrosis may lower measured concentration in advanced disease. Concentration is therefore interpreted alongside damage and copper distribution. Clotting is assessed before sampling to evaluate bleeding risk.

Unexplained ALT elevation lasting over 2 months warrants chronic hepatitis investigation. Fine-needle cytology is insufficient to confirm chronic hepatitis. Adequate samples from several lobes reduce misinterpretation risk. At least 5 samples from at least 2 lobes are recommended for different investigations. Afterwards, your dog is monitored particularly for bleeding.

Liver development in 5 dogs with congenital COMMD1 deficiency was followed by biopsies and blood tests for 42 months. Copper accumulation began at 6 months. Hepatitis developed at 18 months while the dogs still appeared clinically healthy. ALT rose only at 24 months, after tissue changes had developed. Bile acid and albumin results remained within reference ranges throughout.

Treatment

Removing copper and reducing further accumulation

Your vet plans treatment from biopsy findings, copper quantity and general condition. A copper-binding medicine, or chelator, helps remove excess. The most commonly used active substance is D-penicillamine, which increases urinary copper excretion.

A low-copper diet generally continues lifelong. It reduces new copper absorption but does not replace necessary chelation. Most dogs with chronic hepatitis do not need general protein restriction. A balanced home-prepared diet can be formulated with an animal nutrition specialist if needed.

Common D-penicillamine adverse effects include nausea, vomiting, appetite loss and diarrhoea. Less common effects include skin reactions, reduced blood cell counts and urinary protein loss. Excessive copper removal can also cause deficiency.

Prolonged treatment and confirmation of response

Copper-removing treatment is generally prolonged. Severe accumulation in Bedlington Terriers may require particularly prolonged or lifelong medication. Blood tests may show improvement within 1 month of starting treatment. However, ALT does not always normalise even within 6 months.

Repeat biopsy and copper measurement often take place at about 6 months to confirm response. Improved liver blood results alone do not show that tissue copper and inflammation have resolved. Medication may continue if copper reaccumulates despite dietary restriction.

Zinc reduces intestinal copper absorption but acts slowly. It is not used simultaneously with D-penicillamine because they reduce each other's effects. If separate inflammation persists despite copper removal, treatment may include immunosuppressive medication.

Symptomatic nausea treatment can help your dog eat and tolerate chelation. Antioxidants such as vitamin E may support liver cell protection. Abdominal fluid and portal hypertension may need separate care. Medication monitoring also checks blood counts and urinary protein excretion.

Prevention

The Bedlington Terrier COMMD1 test helps prevent transmission of the known inherited form. Carriers are not mated together, and affected dogs are not bred. A normal result does not exclude every cause of copper-associated hepatitis.

A Labrador ATP7B result alone also cannot reliably predict disease. Avoiding unnecessary copper supplements reduces preventable excess intake. Drinking water is considered alongside the main food as a copper source. Early investigation improves the chance of treatment before cirrhosis.

Treats and supplements count towards the overall diet because their copper may undermine treatment. Water from copper pipes can be run for 5 minutes before collecting drinking water for your dog.

Important for dog owners

Record appetite, weight changes, vomiting and diarrhoea before follow-up. Monitor thirst, urination and abdominal size too. Abnormal behaviour or confusion may indicate encephalopathy from liver dysfunction.

Report vomiting or appetite loss beginning during treatment because they may also be adverse drug effects. Checks assess both benefit and harm through blood tests and urine samples if needed. Copper can reaccumulate even on a low-copper diet.

Prepare details of foods, treats and supplements given besides normal meals for your appointment. Genetic interpretation also considers breed because the same variant's association with liver copper may differ between breeds.

Frequently asked questions

Does a high ALT result mean copper storage disease?

Raised ALT indicates liver cell damage but not its cause. Confirming copper-associated hepatitis requires biopsy and tissue copper measurement. Blood copper does not reliably reflect liver accumulation. Ultrasound can also look normal despite chronic hepatitis.

Can a genetically clear Bedlington Terrier develop disease?

The COMMD1 test identifies a particular inherited form, but other causes of accumulation exist. A dog with a normal result therefore still needs investigation if liver enzymes rise or symptoms appear. Genetic testing does not replace liver investigations in a symptomatic dog.

Is low-copper food sufficient treatment?

Diet reduces new intake and generally continues lifelong. It does not replace chelation when accumulated copper must be removed. Some dogs reaccumulate copper despite a low-copper diet.

How quickly do liver blood results improve?

Some dogs show improvement within 1 month of treatment starting. ALT may nevertheless remain raised at 6 months. Repeat biopsy confirms copper reduction and resolution of inflammation if needed.

Can an affected dog have a good life?

Early-diagnosed and treated copper-associated hepatitis generally has a good to very good outlook. Cirrhosis and acute liver failure worsen it. Diet usually continues lifelong, and some dogs also need long-term copper-removing medication.